Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal
- PMID: 222148
- DOI: 10.1016/s0002-9378(16)33076-9
Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal
Abstract
A prospective study of 46 women with prolactin-secreting pituitary adenomas and amenorrhea and/or galactorrhea was performed to determine the influence of the selective transsphenoidal removal of these tumors on pituitary and reproductive function. This procedure was effective in restoring menstrual function in 34 of 41 women and in eliminating lactation in 30 of 40 women. Tumor size and preoperative serum prolactin concentrations were the most important factors in predicting the postoperative disappearance of symptoms. Normal menstrual function returned in 33 of 34 women with tumors less than 2 cm in diameter but in only one of seven women with tumors greater than 2 cm. Similarly, galactorrhea disappeared in 29 of 34 women with tumors less than 2 cm but in only one of six women with larger tumors. Menses returned in 31 of 32 women and galactorrhea disappeared in 25 of 31 women with preoperative serum prolactin levels below 200 ng/ml; conversely, menses returned in only three of nine women and lactation ceased in one of six women with preoperative serum prolactin concentrations above 200 ng/ml. Prolactin concentrations decreased in 42 of 43 patients following the removal of pituitary adenomas and returned to normal in 30. Postoperative pituitary reserves of adrenocorticotropic hormone, growth hormone, luteinizing hormone, and follicle-stimulating hormone were normal in most patients. These data indicate that the removal of prolactin-secreting pituitary adenomas by a neurosurgeon accomplished in this surgical technique is effective in restoring menstrual function and eliminating lactation in most women, especially if the tumor is less than 2 cm in diameter and the preoperative serum prolactin concentration is less than 200 ng/ml.
Similar articles
-
Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.Am J Obstet Gynecol. 1977 Jun 15;128(4):356-63. doi: 10.1016/0002-9378(77)90553-1. Am J Obstet Gynecol. 1977. PMID: 559413
-
Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone or prolactin. A case report.Ann Intern Med. 1978 Sep;89(3):345-8. doi: 10.7326/0003-4819-89-3-345. Ann Intern Med. 1978. PMID: 686546
-
Prolactin-secreting pituitary adenomas. III. Frequency and diagnosis in amenorrhea-galactorrhea.JAMA. 1980 Sep 19;244(12):1329-32. doi: 10.1001/jama.244.12.1329. JAMA. 1980. PMID: 7191013
-
Prolactin secreting pituitary adenomas in women with amenorrhea or galactorrhea.Obstet Gynecol Surv. 1977 Nov;32(11):727-38. doi: 10.1097/00006254-197711000-00016. Obstet Gynecol Surv. 1977. PMID: 337195 Review. No abstract available.
-
Galactorrhea and hyperprolactinemia.Obstet Gynecol Surv. 1983 Dec;38(12):689-700. doi: 10.1097/00006254-198312000-00001. Obstet Gynecol Surv. 1983. PMID: 6361641 Review.
Cited by
-
Somatotropin secretion in hyperprolactinemia.Neurosci Behav Physiol. 1983 Mar-Apr;13(2):146-9. doi: 10.1007/BF01190801. Neurosci Behav Physiol. 1983. PMID: 6686292 No abstract available.
-
Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.Acta Neurochir (Wien). 1990;103(3-4):92-8. doi: 10.1007/BF01407512. Acta Neurochir (Wien). 1990. PMID: 2399846
-
Trends in the management of prolactinomas.Br Med J. 1980 Aug 2;281(6236):338-9. doi: 10.1136/bmj.281.6236.338. Br Med J. 1980. PMID: 7427266 Free PMC article. No abstract available.
-
Diagnosis and management of prolactinomas.Cancer Metastasis Rev. 1986;5(2):125-38. doi: 10.1007/BF00046427. Cancer Metastasis Rev. 1986. PMID: 3549032 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources